Why Sorrento Therapeutics Stock Is Getting Hammered This Week
Despite positive material updates, the biotech's shares couldn't escape the market-wide downturn among growth stocks this week.
Full Article
Why Sorrento Therapeutics Stock Is Getting Hammered This Week
Motley Fool
0 shares
1 views
You might like
Related news coverage
Why Denali Therapeutics Stock Is Sinking This Week
The FDA placed a hold on the company's planned clinical trial of an experimental Alzheimer's disease drug.
Motley Fool